National Drug Authority

Parent institution: Government of Uganda

ROR: 00p21q350

OpenAlex ID: I4405266148

Emergence of multi-acaricide resistant Rhipicephalus ticks and its implication on chemical tick control in Uganda

2016 · Patrick Vudriko, James Okwee-Acai, et al. · Parasites & Vectors · 165

The quality of drinking and domestic water from the surface water sources (lakes, rivers, irrigation canals and ponds) and springs in cholera prone communities of Uganda: an analysis of vital physicochemical parameters

2020 · Godfrey Bwire, David A. Sack, et al. · BMC Public Health · 106

PDF

Chemical tick control practices in southwestern and northwestern Uganda

2018 · Patrick Vudriko, James Okwee-Acai, et al. · Ticks and Tick-borne Diseases · 61

Medicinal plants used for treatment of malaria by indigenous communities of Tororo District, Eastern Uganda

2023 · John R. S. Tabuti, Samuel Baker Obakiro, et al. · Tropical Medicine and Health · 58

PDF

Environmental Surveillance of Vibrio cholerae O1/O139 in the Five African Great Lakes and Other Major Surface Water Sources in Uganda

2018 · Godfrey Bwire, Amanda K. Debes, et al. · Frontiers in Microbiology · 53

PDF

Opportunities and challenges of leveraging COVID-19 vaccine innovation and technologies for developing sustainable vaccine manufacturing capabilities in Africa

2023 · Bavesh D Kana, Patrick Arbuthnot, et al. · The Lancet Infectious Diseases · 50

PDF

Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants

2014 · Ronald Kiguba, Charles Karamagi, et al. · BMJ Open · 45

PDF

Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned

2020 · Jane H. Mashingia, Vincent Ahonkhai, et al. · PLoS Medicine · 42

PDF

The European Medicines Agency’s scientific opinion on oral fexinidazole for human African trypanosomiasis

2019 · Eric Pelfrene, Martin Harvey Allchurch, et al. · PLoS neglected tropical diseases · 41

Navigating duplication in pharmacovigilance databases: a scoping review

2024 · Ronald Kiguba, Gerald Isabirye, et al. · BMJ Open · 39

PDF

Coming together to improve access to medicines: The genesis of the East African Community’s Medicines Regulatory Harmonization initiative

2020 · Hiiti Sillo, Aggrey Ambali, et al. · PLoS Medicine · 38

PDF

Evidence-based tick acaricide resistance intervention strategy in Uganda: Concept and feedback of farmers and stakeholders

2017 · Patrick Vudriko, James Okwee-Acai, et al. · Ticks and Tick-borne Diseases · 31

The Burden of Adverse Drug Reactions Due to Artemisinin-Based Antimalarial Treatment in Selected Ugandan Health Facilities: An Active Follow-Up Study

2018 · Helen Byomire Ndagije, Victoria Nambasa, et al. · Drug Safety · 30

PDF

Drug safety in Africa: a review of systems and resources for pharmacovigilance

2023 · Helen Byomire Ndagije, David Walusimbi, et al. · Expert Opinion on Drug Safety · 29

Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study

2012 · Ambrose O Talisuna, Penny Grewal Daumerie, et al. · Malaria Journal · 28

PDF

Facilitators and Barriers to Uptake of the Med Safety Mobile App for Adverse Drug Reaction Reporting by Health Workers in Uganda: A Qualitative Study

2023 · Ronald Kiguba, Henry Zakumumpa, et al. · Drug Safety · 27

PDF

National Studies as a Component of the World Health Organization Initiative to Estimate the Global and Regional Burden of Foodborne Disease

2015 · Robin J. Lake, Brecht Devleesschauwer, et al. · PLoS ONE · 26

PDF

Medication Error Disclosure and Attitudes to Reporting by Healthcare Professionals in a Sub-Saharan African Setting: A Survey in Uganda

2015 · Ronald Kiguba, Paul Waako, et al. · Drugs - Real World Outcomes · 26

PDF

First regulatory inspections measuring adherence to Good Pharmacy Practices in the public sector in Uganda: a cross-sectional comparison of performance between supervised and unsupervised facilities

2016 · Birna Trap, Kate Kikule, et al. · Journal of Pharmaceutical Policy and Practice · 25

PDF

Social marketing of pre-packaged treatment for men with urethral discharge (Clear Seven) in Uganda

2003 · B Jacobs, F S K Kambugu, et al. · International Journal of STD & AIDS · 25

Targeted Spontaneous Reporting of Suspected Renal Toxicity in Patients Undergoing Highly Active Anti-Retroviral Therapy in Two Public Health Facilities in Uganda

2015 · Helen Ndagije, Victoria Nambasa, et al. · Drug Safety · 23

PDF

Patient experiences of sexual dysfunction after transition to dolutegravir-based HIV treatment in mid-Western Uganda: a qualitative study

2022 · Henry Zakumumpa, Ronald Kiguba, et al. · BMC Infectious Diseases · 22

PDF

Provider perspectives on the acceptability and tolerability of dolutegravir-based anti-retroviral therapy after national roll-out in Uganda: a qualitative study

2021 · Henry Zakumumpa, Freddy Eric Kitutu, et al. · BMC Infectious Diseases · 22

PDF

Implementation and performance of haemovigilance systems in 10 sub-saharan African countries is sub-optimal

2021 · Washington T. Samukange, Verena Kluempers, et al. · BMC Health Services Research · 22

PDF

Evaluation of the Clinical Use of Ceftriaxone among In-Patients in Selected Health Facilities in Uganda

2021 · Paul Kutyabami, Edson Ireeta Munanura, et al. · Antibiotics · 22

PDF

Works count: 109

Citation count: 2,702